Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors†
Abstract
A new strategy for converting antipsychotic
* Corresponding authors
a
Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500046, India
E-mail:
manojitpal@rediffmail.com
b Chemistry Division, Institute of Science and Technology, JNT University, Kukatpally, Hyderabad 500072, India
c Zephase Therapeutics Pvt. Ltd (An incubated company at the Institute of Life Sciences), University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India
A new strategy for converting antipsychotic
D. R. Gorja, S. Mukherjee, C. L. T. Meda, G. S. Deora, K. Lalith Kumar, A. Jain, G. H. Chaudhari, K. S. Chennubhotla, R. K. Banote, P. Kulkarni, K. V. L. Parsa, K. Mukkanti and M. Pal, Org. Biomol. Chem., 2013, 11, 2075 DOI: 10.1039/C3OB27424A
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content